Polymer Biomaterials Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
Polymer biomaterials are produced by monomeric units that form larger structures by bonding covalently. Polymer biomaterials play a major role in tissue engineering, wherein they can be introduced into body tissue as part of an implanted medical device or used to replace an organ, bodily function. They are also used in surgical devices, and for drug delivery applications. The global polymer biomaterials market is expanding at a rapid pace, due to the increase in health care expenditure and rise in geriatric population.
Growth in
aging population, who are primary consumers of polymer biomaterials in
form of biomedical implants, is driving the polymer
biomaterials market. Increase in research activities, technological
advancements, and rise in investments in the polymer biomaterial sector are
major factors propelling the market. Key advantages of polymeric biomaterials
vis-Ã -vis metal or ceramic biomaterials are ease of manufacturability to
produce various shapes (latex, film, sheet, fibers, etc.), corrosion
resistance, and availability with desired mechanical and physical properties.
The required properties of polymeric biomaterials are similar to that of other
biomaterials. These include biocompatibility, sterilizability, and adequate
mechanical and physical properties. Furthermore, advancements in the medical
technology have facilitated the implant of these polymer biomaterials into the
human body. This, in turn, is a prominent factor augmenting the polymer
biomaterials market. These key drivers provide lucrative opportunities to the
polymer biomaterials market.
Request
PDF brochure
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31922
However,
implementation of stringent safety and validation regulations, compatibility
issues, and difficulty in wearing/implanting the products are some of the
factors hampering the polymer biomaterials market. Strict regulatory
biocompatibility requirement for approval of biomaterials is also inhibiting
the market. Moreover, polymers are costly. This is also expected to adversely
affect market growth.
Based on
type of polymer material, the polymer biomaterials market can be segmented into
nylon, silicone rubber, polyethylene, polyester, polymethylmethacrylate (PMMA),
and polyvinylchloride (PVC). Polymethylmethacrylate (PMMA) is projected to be
the dominant segment during the forecast period due to the rise in applications
in orthopedics, dental, and ophthalmology fields. PMMA has high degree of
compatibility with the human tissue; therefore, it is often used for the
replacement of intraocular lenses in eyes. For instance, it is used in the
treatment of cataracts. PMMA is also commonly used to make dentures and dental
filling materials. It is also used as a wrinkle- or scar-reducing compound in
cosmetic surgeries
More
Trending Reports
In terms
of end-use, the polymer biomaterials market can be classified into
cardiovascular, ophthalmology, orthopedics, dental, plastic surgery, wound
healing, tissue engineering, and neurological disorders/central nervous system.
The cardiovascular end-use segment held the leading share of the market in 2016
owing to the increase in medical cases related to cardiac disorders. It was
followed by the orthopedics segment.
Buy Now
https://www.transparencymarketresearch.com/checkout.php?rep_id=31922<ype=S
Based on geography,
the polymer biomaterial market can be divided into North America, Latin
America, Asia Pacific, Europe, and Middle East & Africa. North America and
Europe are technologically mature regions; thus, they are expected to be the
dominant regions of the market during the forecast period. Rise in polymer
biomaterials-based research, increase in demand for plastic surgeries, and
growth in prevalence of cardiovascular diseases are estimated to drive market
growth in North America and Europe. The polymer biomaterials market in Asia
Pacific is projected to expand due to the increase in awareness about polymer
biomedical devices for usage in cardiovascular, orthopedics, and dental
applications in emerging economies such as China, India, and Japan. Countries in
Middle East & Africa consist of untapped markets. This provides an
opportunity to market players to expand their share in these regions.
Key
players operating in the global polymer biomaterials market include, Bayer AG,
Wright Medical Technology, Inc., Evonik Industries AG, Osteotech, Inc., Biomet,
Inc. and Berkeley Advanced Biomaterials, Inc.
Request
Discount
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=31922
Comments
Post a Comment